Poster List
P001
Exploring new strategies for diagnosis of TB and other pathogens
The impact of M. tuberculosis complex lineage and isoniazid resistance mutations on bedaquiline susceptibility
Kakha Mchedlishvili, Medical Parasitology and Infection Biology, SwissTPH, Allschwil, Switzerland / University of Basel, Basel, Switzerland
P002
Exploring new strategies for diagnosis of TB and other pathogens
From Canine Tuberculosis to Human Infection: a Case Report from Croatia
Irena Reil, Croatian veterinary institute
P003
Exploring new strategies for diagnosis of TB and other pathogens
Diagnostic performance of computer-aided lung ultrasound for facility-based screening of pulmonary tuberculosis in Benin, Mali and South Africa: protocol of a multicentre prospective cohort study
Evelyne Knüsel, Swiss Federal Institute of Technology, Lausanne, Switzerland
P004
Exploring new strategies for diagnosis of TB and other pathogens
Differentiation of Mycobacterium abscessus subspecies by MALDI-TOF MS: machine learning models and spectral biomarker analysis
Mark Gutiérrez-Pareja, Gregorio Marañón Health Research Institute (IiSGM) / Clinical Microbiology and Infectious Diseases Department, Gregorio Marañón General University Hospital, Madrid, Spain
P005
Exploring new strategies for diagnosis of TB and other pathogens
Validation of Facemask-Based Exhaled Breath Aerosol Molecular Testing for Tuberculosis and Respiratory Viruses
Ilaria Iannucci, IRCCS San Raffaele Scientific Institute, Milan, Italy / Vita-Salute San Raffaele Univeristy, Milan, Italy
P006
Exploring new strategies for diagnosis of TB and other pathogens
Performance evaluation of a new interferon gamma release assay for tuberculosis
Qian Feng, Roche Diagnostics International AG, Rotkreuz, Switzerland
P009
Innovative models to study mycobacterial infections
Characterising subpopulations in mixed infections of M. tuberculosis using WGS read coverage
Viktoria Brunner, University of Oxford
P010
Innovative models to study mycobacterial infections
Analysis of Mycobacterium chimaer a strains isolated from contaminated Heater-Cooler Units using Fourier Transform Infrared Spectroscopy
Beatrice Margherita Bonazzi, Microbiology Unit, IRCSS Azienda Ospedaliero-Universitaria di Bologna, Italy / Alma Mater Studiorum University of Bologna, Italy
P011
Innovative models to study mycobacterial infections
Impact of bacterial growth phases on intracellular replication, host response, and antibiotic sensitivity in non-tuberculous mycobacteria
Tânia Silva, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto/ ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Portugal
P012
Innovative models to study mycobacterial infections
In vitro Mycobacterium fortuitum priming enhances pro-inflammatory and bactericidal responses of caprine alveolar macrophages upon homologous re-stimulation.
Miriam Blay Benach, Institut de Recerca i Tecnologia Agroalimentàries (IRTA), Animal Health, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia, Spain / Unitat Mixta d'Investigació Institut de Recerca i Tecnologia Agroalimentàries (IRTA)-UAB en Sanitat Animal, CReSA, Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia, Spain
P013
Innovative models to study mycobacterial infections
MIPERA: a new tool to explore Mycobacterium tuberculosis evolution within hosts
Mireia Coscolla, CSIC
P014
Molecular biology and mycobacterial evolution
Genomic Surveillance of rifampicin-resistant tuberculosis in the Western Cape Province of South Africa in the BPaLM Era
Wilma Quispe Rojas, Tuberculosis Omics Research Consortium, Department of Family Medicine and Population Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
P015
Molecular biology and mycobacterial evolution
Genomic diversity and resistance profiles of clinically relevant nontuberculous mycobacteria in Denmark
Xenia E S Iversen, International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen S, Denmark
P016
Molecular biology and mycobacterial evolution
Development of a NanoLuc-based reporter system to assess the impact of Rv0678 mutations associated with bedaquiline resistance
Francesca Boldrin, Dipartimento di Medicina Molecolare
P017
Molecular biology and mycobacterial evolution
Bedaquiline resistance in Mycobacterium tuberculosis strains in Russia remains acquired during long-term treatment rather than spread through recent transmission
Igor Mokrousov, Laboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, Russia
P018
Molecular biology and mycobacterial evolution
Determination of the technical and biological variability in Mycobacterium tuberculosis Illumina whole genome sequencing replicates to support precision epidemiology.
Richard Anthony, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
P019
Molecular biology and mycobacterial evolution
Phylogenomic analysis of Mycobacterium abscessus reveals distinct Amazonian clusters and inter-regional dissemination in Brazil
Jody E Phelan, Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK / Statens Serum Institut, Copenhagen, Denmark
P020
Molecular biology and mycobacterial evolution
High resolution transmission clustering with Nanopore sequencing: insights from an extended tuberculosis cluster in the Netherlands
Noud Hermans, Diagnostics Team, Division of TB Elimination & Health Systems Innovations, KNCV Tuberculosis Foundation, The Hague, The Netherlands/ Department Bacterial Surveillance and Response, Center for Infectious Disease Control, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
P021
Molecular biology and mycobacterial evolution
Mycobacterium bovis genetic drifts following BCG vaccination campaigns in Madagascar : phylogenomic studies from humans and cattle clinical isolates
Fanantenana Randria-Andrianomanana, Mycobacteria Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar
P022
Molecular biology and mycobacterial evolution
Prevalence and genotypic structure of mixed cultures of Mycobacterium tuberculosis among patients with HIV-associated tuberculosis in St. Petersburg, Russia
Igor Mokrousov, Laboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, St. Petersburg, Russia
P023
Molecular biology and mycobacterial evolution
Molecular epidemiology and phylodynamic insights into multidrug-resistant Mycobacterium tuberculosis transmission in France, 2018–2024
Thierry Wirth, EPHE, PSL University, Paris, France / Institut de Systématique, Evolution, Biodiversité, ISYEB, Muséum national d’Histoire naturelle, CNRS, Sorbonne Université, EPHE, Université des Antilles, Paris, France
P024
Molecular biology and mycobacterial evolution
Tracing the Invisible: Whole-genome sequencing reveals substantial genetic diversity and limited recent zoonotic transmission of Mycobacterium bovis in Northwestern Spain
Víctor Lorente-Leal, Departamento de Fisiología, Genética y Microbiología, Facultad de Ciencias Biológicas, Universidad Complutense de Madrid, Madrid, Spain / Centro de Vigilancia Sanitaria Veterinaria (VISAVET), Universidad Complutense de Madrid, Madrid, Spain
P025
Molecular biology and mycobacterial evolution
Contribution of whole genome sequencing for species level identification and macrolides resistance detection within the Mycobacterium fortuitum complex
Nour Ben Salem, AP-HP Nord Université Paris Cité, Hôpital Bichat, Service de mycobactériologie spécialisée et de référence, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (CNR-MyRMA), F-75018 Paris, France/ IAME UMR 1137, Université Paris Cité and Sorbonne Paris Nord, Inserm, F-75018 Paris, France/ AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Service de Bactériologie, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (CNR MyRMA), F-75013 Paris, France/ Sorbonne Université, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, F-75013 Paris, France
P026
Molecular biology and mycobacterial evolution
Re-activation or re-infection: whole genome sequence analysis of recurrent tuberculosis samples in a low-incidence setting
Sara Truden, MSc
P027
Molecular biology and mycobacterial evolution
Multi-drug resistant tuberculosis transmission in Estonia, Latvia, and Lithuania (2017–2025): an observational study
Laima Vasiliauskaite, Vilnius University, Faculty of Medicine, Institute of Biomedical Sciences, Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Vilnius, Lithuania / Centre of Laboratory Medicine, Laboratory of Infectious Diseases and Tuberculosis, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
P029
Molecular biology and mycobacterial evolution
Europe/Russian W148, Central Asia Outbreak, and Ukraine Outbreak Lineage 2/Beijing Mycobacterium tuberculosis Strains Drive Drug-Resistant Tuberculosis in Ukraine: A Nationwide Whole-Genome Sequencing Study
Dmytro Butov, Research Center Borstel - Leibniz Lung Center, Borstel, Germany
P030
Molecular biology and mycobacterial evolution
Mycobacterium tuberculosis DNA recovery from and stability at high temperature on Copan FLOQSwabs
Cristiano Sabelli, Copan Italia Spa
P031
Molecular biology and mycobacterial evolution
Beijing genotype and its Russian successful clone B0/W148 are dominant among pre-extensively drug resistant Mycobacterium tuberculosis strains in Omsk, Russia
Igor Mokrousov, Laboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, Russia
P032
Molecular biology and mycobacterial evolution
Whole- genome sequencing– based detection of mixed Mycobacterium tuberculosis infections in drug- resistant tuberculosis: Clinical and phylogenetic insights from a prospective Ukraine cohort
Viola Dreyer, 1. Research Center Borstel - Leibniz Lung Center, Molecular and Experimental Mycobacteriology
P033
Molecular biology and mycobacterial evolution
Unsupervised Clustering and LLM for Exploring Large MTBC Genomic Databases: Application to Portuguese-speaking SRAs in TBAnnotator
Clément Lecarpentier, Université de Franche-Comté, France / Université Paris-Saclay, France
P034
Molecular biology and mycobacterial evolution
Baseline variation in bedaquiline-associated genes in a bedaquiline-naïve TB population in Grande Comore using Deeplex-MycTB XL on sputum
Sofie M. Braet, Institute of Tropical Medicine Antwerp, Belgium
P035
Molecular biology and mycobacterial evolution
Optimised long read sequencing enables early species identification from MGIT cultures with high concordance to short read sequencing
Catriona S Baker, University of Oxford
P036
Molecular biology and mycobacterial evolution
Genomic analysis of human and animal Mycobacterium bovis in Northern Ireland reveals evidence of pre-bottleneck lineage persistence
Zoe Johnston, OneZoo/Queens University Belfast/Agri-Food and Biosciences Institute/Belfast Health and Social Care Trust
P037
Molecular biology and mycobacterial evolution
Comparative genomics reveals the evolutionary diversification of asparaginases across the genus Mycobacterium
Arnau Seguí Moll, Departament de Genètica i Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193, Bellaterra, Barcelona, Spain
P038
Molecular biology and mycobacterial evolution
Discrepancies between phenotypic and genotypic susceptibility test results in Mycobacterium tuberculosis.
Nelly Ciobanu, Institute of Pneumology / State University of Medicne and Pharmacy
P039
Molecular biology and mycobacterial evolution
Reliable detection of Mycobacterium tuberculosis Haarlem genotype by real-time PCR method and its use for screening in local collections
Violeta Valcheva, Laboratory of Molecular Biology of Mycobacteria, Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, Bulgaria
P040
Molecular biology and mycobacterial evolution
Initial identification of an XDR-TB strain featuring the rpoB I491F mutation in Hungary
Renáta Vincze, National Reference Laboratory for Mycobacteriology, Hungary
P041
New diagnostics for MDR-TB
Diagnostic Performance of STANDARD™ M10 Multidrug-resistant Tuberculosis Assay in smear-negative samples: fresh vs frozen samples
Federica Sorella, University of Bologna
P042
New diagnostics for MDR-TB
The impact of allele frequency and DNA input quantity on the reproducibility of variant detection by the Deeplex Myc-TB assay
Miguel de Diego Fuertes, Tuberculosis Omics Research Consortium, Department of Family Medicine and Population Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
P044
New diagnostics for MDR-TB
Zinc supplementation on thin-layer agar enhances primary isolation of Mycobacterium tuberculosis, without affecting its accuracy for direct drug-susceptibility testing
Jerome Ndayisenga, National Reference Laboratory, Biomedical Services Department, Rwanda Biomedical Centre, Kigali, Rwanda
P045
New diagnostics for MDR-TB
Stool-based testing: sensitivity of stool swabs and Xpert MTB/XDR testing as follow up test for drug-resistant tuberculosis in children and people living with HIV in Tanzania
petra de Haas, KNCV TB foundation, The Hague, The Netherlands
P046
New diagnostics for MDR-TB
Detection of Mycobacteria tuberculosis (MTB) and mutations associated with Isoniazid and Rifampicin resistance from clinical specimens using BDMAX-MDR TB assay in a Tuberculosis reference laboratory.
HP Liang, Singapore General Hospital
P047
New diagnostics for MDR-TB
Expanding molecular TB diagnostics beyond sputum: Performance assessment across diverse pulmonary and extrapulmonary sample materials for molecular detection of M. tuberculosis complex and first-line drug resistance
Ralf Spannaus, Bruker - Hain Lifescience GmbH, Nehren, Germany
P048
Omics in diagnosis of mycobacteria infection and disease
Genomic insights and treatment outcomes of non-tuberculous mycobacterial infections in Ukraine (2022–2024)
Margo Diricks, Research Center Borstel
P049
Omics in diagnosis of mycobacteria infection and disease
Phylogenomics and Macrolide Resistance in Mycobacterium abscessus Complex Isolates from the Brazilian Amazon
KVB Lima, Bacteriology and Mycology Section, Instituto Evandro Chagas, Ananindeua, Brazil / Postgraduate Program in Parasitic Biology in the Amazon, Universidade do Estado do Pará, Belém, Brazil /Postgraduate Program in Epidemiology and Health Surveillance, Instituto Evandro Chagas, Ananindeua, Brazil / Brazilian Tuberculosis Research Network, Rede Brasileira de Pesquisa em Tuberculose, Rio de Janeiro, Brazil.
P050
Omics in diagnosis of mycobacteria infection and disease
Bovine tuberculosis: assessment of proteomic analysis as quality control tools for IFNg test reagents
Zoë Vandenberghe, Sciensano / University of Antwerp
P051
Omics in diagnosis of mycobacteria infection and disease
Drug Resistance, Clinical Characteristics, and Treatment Outcomes Associated With Mycobacterium tuberculosis Lineage 2 in Georgia, 2014-2020
Dmytro Butov, Research Center Borstel, Leibniz Lung Center, Borstel, Germany
P052
Omics in diagnosis of mycobacteria infection and disease
First whole-genome sequencing study of drug-resistant Mycobacterium tuberculosis in Ceará, Brazil: comparative insights from phenotypic and genotypic tests
CC Frota, Pos-graduate Program in Pathology, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
P053
Omics in diagnosis of mycobacteria infection and disease
Local emergence and ongoing transmission of a multidrug-resistant Mycobacterium tuberculosis Haarlem outbreak in French Polynesia.
Borowiecka Angelika, Institut de Systématique, Évolution, Biodiversité (ISYEB),EPHE/PSL University/Muséum national d’Histoire naturelle/CNRS/Sorbonne Université/Université des Antilles, Paris
P054
Omics in diagnosis of mycobacteria infection and disease
Comparative genomics reveals subspecies clustering and population structure in historical Mycobacterium avium isolates
Xenia E S Iversen, International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark
P055
Omics in diagnosis of mycobacteria infection and disease
Long-read sequencing of Mycobacterium tuberculosis is comparable to short-read sequencing for antimicrobial resistance prediction and epidemiological studies.
Matthew Colpus, University of Oxford
P056
Omics in diagnosis of mycobacteria infection and disease
Respiratory microbiome profiling by 16S rRNA sequencing in bacteriologically confirmed and clinically diagnosed tuberculosis patients in rural Mozambique
Belén Saavedra Cervera, Wellcome Sanger Institute / Centro de Investigação em Saúde de Manhiça
P057
Omics in diagnosis of mycobacteria infection and disease
M. avium case study: investigation of genome alterations during resistance development
Xenia E S Iversen, International Reference Laboratory of Mycobacteriology, Statens Serum Institut, 2300 Copenhagen S, Denmark
P058
Omics in diagnosis of mycobacteria infection and disease
Bovine tuberculosis studies at different levels: serum kinetics, lipid profile, and gene expression patterns, for diagnostic and therapeutic purposes
Gloria Guerrero Manriquez, Unidad Académica de Ciencias Biológicas de la Universidad Autónoma de Zacatecas
P059
Other
Quinolone derivatives as prospective pharmaceuticals against multidrug-resistant Mycobacterium tuberculosis and Mycobacterium abscessus
Magdalena Kuzioła, Institute of Medical Biology, Polish Academy of Sciences, Mycobacterium Genetics and Physiology Lab, Lodz / The Bio-Med-Chem Doctoral School of the University of Lodz and Lodz Institutes of the Polish Academy of Sciences, Lodz
P060
Other
Mucosal BCG and prime-boost vaccination strategies enhance functional reprogramming of alveolar macrophages in goats.
Miriam Blay-Benach, Institut de Recerca i Tecnologia Agroalimentàries (IRTA), Animal Health, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia, Spain / Unitat Mixta d'Investigació Institut de Recerca i Tecnologia Agroalimentàries (IRTA)-UAB en Sanitat Animal, CReSA, Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia, Spain
P061
Other
NextMTB: An Evolved MTBseq-Based Nextflow Pipeline for Comprehensive Genomic Surveillance of Mycobacterium tuberculosis
Federico Di Marco, Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy / Research Fellow funded by the National Centre for Disease Prevention and Control (CCM), Italy
P062
Other
Cross-Border Molecular Epidemiology of Human Mycobacterium bovis Isolates from the Island of Ireland using Whole Genome Sequencing
Emma Roycroft, Irish Mycobacteria Reference Laboratory / Trinity College Dublin
P063
Other
Boron clusters as modulators of antimycobacterial activity of isoniazid
ANNA BRZOSTEK, Intitute for Medical Biology Poilish Academy of Sciences
P064
Other
Two proposed novel species of the Mycobacterium avium complex originating from Frankfurt am Main and the Taunus region, Germany
Max Kevane-Campbell, Goethe University Frankfurt, University Hospital, Department of Internal Medicine, Infectious Diseases, Frankfurt am Main, Germany. / Goethe University Frankfurt, Mycobacterial Infection Research Unit (MIRU), Frankfurt am Main, Germany. / Goethe University Frankfurt, University Hospital, Institute of Medical Microbiology and Infection Control, Frankfurt am Main, Germany.
P065
Other
Genomic insights into Mycobacterium bovis diversity and interspecies transmission in animals from North-Central Spain.
Víctor Lorente-Leal, Departamento de Fisiología, Genética y Microbiología, Facultad de Ciencias Biológicas, Universidad Complutense de Madrid, Madrid, Spain / Centro de Vigilancia Sanitaria Veterinaria (VISAVET), Universidad Complutense de Madrid, Madrid, Spain
P066
Other
Biophysical and functional profiling of Rv0678 variants to inform genotype-phenotype correlations in bedaquiline-resistant Mycobacterium tuberculosis
Ilaria Bortoluzzi, University of Siena, University of Padova
P067
Other
Tuberculosis in people living with HIV in Latvia: evaluating current screening practice and exploring factors associated with disease development
Renate Ranka, Riga Stradins University
P068
Other
Understanding the Role of IS6110 in bedaquiline resistance in Mycobacterium tuberculosis
Alma Zinola, Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
P069
Other
The Vortex-Genie: A low-cost, portable bead-beating alternative for Mycobacterium tuberculosis complex DNA extraction
Noud Hermans, Diagnostics Team, Division of TB Elimination & Health Systems Innovations, KNCV Tuberculosis Foundation, The Hague, The Netherlands/ Department Bacterial Surveillance and Response, Center for Infectious Disease Control, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
P070
Other
Non-tuberculous mycobacteria-based immunomodulation as a prophylactic strategy against pulmonary infections
Esther Julián, Departament de Genètica i Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain
P071
Other
High prevalence of latent tuberculosis infection in an indigenous population of the Colombian Amazon region: a population-based cross-sectional study
Jorge Alfredo Morcillo Muñoz, Hospital Universitario Departamental de Nariño, Pasto, Colombia/ Universidad de Nariño, Pasto, Colombia
P072
Other
Variants in bedaquiline resistance-associated genes and correspondent minimal inhibitory concentrations in isolates from Georgia prior bedaquiline introduction
elisa Ardizzoni, Institute of Tropical Medicine Antwerp
P073
Other
Exploring lineage effects in the multi-centric “TB Sequel 1” cohort at the time of tuberculosis diagnosis
Lea Jäger, Molecular and Experimental Mycobacteriology, Research Center Borstel, DE
P074
Other
Reliable identification of M. tuberculosis complex and the clinically most relevant NTM species directly from pulmonary specimens using multiplex PCR
Ralf Spannaus, Bruker - Hain Lifescience GmbH, Nehren, Germany
P075
Other
Benchmarking genome assemblers for mycobacteria: a species-specific evaluation across short-read, long-read, and hybrid sequencing strategies
Arash Ghodousi, Vita-Salute San Raffaele University
P076
Other
Phenotypic Isoniazid Resistance in Mycobacterium tuberculosis Isolates Genotypically Susceptible by Commercial Molecular Assays: Potential Role of the katG p.Trp412Cys Mutation
Francesca Benini, University of Bologna
P077
Other
Hidden in the pipes: high prevalence of non-tuberculous mycobacteria in household water in Northern Germany
Fateme Ghoroghi, Research Center Borstel
P078
Other
Mincle and TLRs coordinate macrophage-driven antitumour responses to mycobacterial lipids
Esther Julián, Departament de Genètica i Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain
P079
Other
Low-Allele Frequency Rv0678 variants – do they influence decision-making in clinical care?
Annelies Van Rie, University of Antwerp
P080
Other
Mycobacterium tuberculosis (MTB) or non-tuberculous mycobacterium (NTM)?
Elena Graglia, Infectious Disease department, Nino Baglieri Hospital, Modica, Italy
P081
Other
Evaluation of performance of the MTB-Card in detecting Mycobacterium Tuberculosis Complex DNA in samples stored at 4°C up to 5 days
Miriam Ciccarelli, University of Bologna
P082
Other
Evaluation of an AI-based digital solution for interpretation of VISITECT CD4- Advanced Disease assay results in low- and middle income settings
petra de Haas, KNCV Tuberculosefonds
P083
Other
Exploring Mycobacteria as a Source of Therapeutic L-Asparaginases with Antileukemic Potential
Arnau Seguí Moll, Departament de Genètica i Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193, Bellaterra, Barcelona, Spain
P084
Omics in diagnosis of mycobacteria infection and disease
Exploring the Mycobacterium terrae complex: integrating Genome-Based Species Delineation with Antimicrobial Susceptibility testing.
Corentin Poignon, Sorbonne Université, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, France / AP-HP. Sorbonne Université, Hôpital Pitié-Salpêtrière, Laboratoire de Bactériologie, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux Paris, France
P085
Omics in diagnosis of mycobacteria infection and disease
Machine learning-enhanced MALDI-TOF enables accurate discrimination between Mycobacterium intracellulare subsp . intracellulare and M. intracellulare subsp . chimaera .
Corentin Poignon, Sorbonne Université, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, France / AP-HP. Sorbonne Université, Hôpital Pitié-Salpêtrière, Laboratoire de Bactériologie, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux Paris, France
P086
Recent advances in research on mycobacterial pathogenesis
Mucosal and parenteral BCG-based vaccination strategies differentially modulate Th1 immune responses i ntensity and confer protection against Mycobacterium caprae in goats.
Patricia Cuenca Lara, Unitat Mixta d’Investigació Institut de Recerca i Tecnologia Agroalimentàries (IRTA)-UAB en Sanitat Animal, CReSA, Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia, Spain / Institut de Recerca i Tecnologia Agroalimentàries (IRTA), Animal Health, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia, Spain
P087
Recent advances in research on mycobacterial pathogenesis
ESCAPE-TB - Eutectic Solutions for Controlled and Advanced Pulmonary Enhancement in Tuberculosis
Mafalda Sarraguça, LAQ-REQUIMTE, Faculty of Pharmacy, University of Porto, Portugal
P088
Revisiting microscopy
Beyond microscopy: evaluation of the MTB-Card molecular test for the rapid diagnosis of tuberculosis
Paolo Caiazza, University of Bologna
P089
Therapeutic strategies for NTM
development of novel inhaled aj-099 for m. tuberculosis and ntm lung infection
Hee-Jong (Jason) Hwang, A&J Science, Republic of Korea
P090
Therapeutic strategies for NTM
Validation of Sensititreᵀᴹ RAPMYCO2 for Susceptibility Testing of Rapidly Growing Mycobacteria
Syn Yu Chua, Singapore General Hospital
P091
Therapeutic strategies for NTM
Distribution of Mycobacterium chimaera in Denmark 2012–2020 and development of a qPCR assay for detection in Heater–Cooler Units.
Erik Michael Rasmussen, International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark
P092
Therapeutic strategies for NTM
Mycobacterium avium complex in Portugal: evaluation of the last 10 years
Sofia Santos, Instituto Nacional de Saúde Dr. Ricardo Jorge - Porto
P093
Therapeutic strategies for NTM
False-positive linezolid phenotypic resistance in Mycobacterium tuberculosis likely due to mixed infection with non-tuberculous mycobacteria: a case report
Wilma Quispe Rojas, Tuberculosis Omics Research Consortium, Department of Family Medicine and Population Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium